Everolimus tablets technical specification:
| Product Name: | Everolimus Tablets 0.25 mg |
| Brand Name: | Generic |
| Strength: | 0.25mg, 0.5mg, 0.75mg, 5mg, 10mg |
| Dosage Form: | Tablet (uncoated) |
| Route of Administration: | Via Oral Route |
| Packing: | 10s,30s,50s,100s |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics) |
| Documents: | COA, MOA, Stability Studies, GMP |
| Therapeutic use: | Immunosuppressant & Anticancer |
| Indication: | Everolimus is used for prevention of organ rejection in transplant patients. It is also used in combination with other medicines to treat cancers of breast, pancreas, lungs and kidney. |
| Storage: | Store at a temperature not exceeding °C. Protect from light & Moisture. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
Everolimus Tablets 0.25 mg
Everolimus Tablets 0.5 mg
Everolimus Tablets 0.75 mg
Everolimus Tablets 5 mg
Everolimus Tablets 10 mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each uncoated tablet contains:
Everolimus BP ………….0.25mg
THERAPEUTIC INDICATIONS:
Everolimus is used for prevention of organ rejection in transplant patients. It is also used in combination with other medicines to treat cancers of breast, pancreas, lungs and kidney.
CAUTION & SCHEDULE:
Keep the medicine out of reach of children.
Refer accompanying package insert for detailed dosage, directions of use and precautions.
SCHEDULE: SCHEDULE H PRESCRIPTION: WARNING: To be sold by retail on the prescription of medical representative/oncologist/Nephrologist only.
STORAGE & DOSAGE:
Storage: Store at a temperature not exceeding 25°C. Protect from light & Moisture.
Dosage: As directed by the Physician.